CENOFI AMFY Kit (Mifepristone and Misoprostol) Used for Early Pregnancy Termination up to 70 Days
Cenofi AMFY Kit (Mifepristone and Misoprostol) is a combination medication used for the medical termination of early pregnancy (up to 9 weeks or 63 days of gestation). The kit contains two medicines that work together: Mifepristone, an anti-progesterone agent that blocks the hormone progesterone needed to sustain a pregnancy, and Misoprostol, a prostaglandin analogue that causes the uterus to contract and expel the pregnancy.
Product Overvciew
CENOFI AMFY Kit is a specialized combination therapy designed for the medical termination of pregnancy (medical abortion). It contains two distinct medications, Mifepristone and Misoprostol, which work together as a non-surgical alternative to end an early, intrauterine pregnancy. This kit is typically indicated for pregnancies up to 10 weeks (70 days) of gestation, providing a safe and effective clinical solution under strict medical supervision.
Product Composition
- Mifepristone Tablet: 1 tablet containing 200 mg of Mifepristone.
- Misoprostol Tablets: 4 tablets, each containing 200 mcg of Misoprostol (total 800 mcg).
- Total Pack: One combipack sachet/blister containing the 1+4 tablet regimen.
Product Specification
| Feature | Details |
| Drug Class | Antiprogestogen and Prostaglandin Analogue |
| Therapeutic Use | Medical abortion (Early intrauterine pregnancy termination) |
| Gestation Limit | Up to 63–70 days (10 weeks) from the last menstrual period |
| Storage | Store in a cool, dry place below 30°C |
| Mechanism Category | Hormonal blockade and uterine contraction induction |
Mechanism of Action
- Progesterone Blockade: Mifepristone acts as a potent progestin antagonist, binding to progesterone receptors and blocking the effects of the hormone required to maintain the uterine lining.
- Uterine Priming: By inhibiting progesterone, the drug causes the lining of the uterus to break down and softens the cervix, preparing the body for the expulsion of the pregnancy.
- Uterine Contractions: Misoprostol, a synthetic prostaglandin, is administered 24–48 hours later to stimulate strong myometrial contractions.
- Expulsion Process: The combined action leads to the opening of the cervix and the shedding of the uterine contents, effectively completing the medical termination of pregnancy.
Key Benefits
- Non-Surgical Option: Offers a private and less invasive method compared to surgical procedures for early pregnancy termination.
- High Success Rate: Clinically proven to be highly effective when the 1+4 tablet regimen is followed within the recommended timeframe.
- Privacy and Comfort: Allows the latter part of the process to occur in a home setting (where legally permitted and clinically advised).
- Avoids Anesthesia: Does not require general or local anesthesia, reducing the risks associated with sedatives and invasive surgical instruments.
- Standardized Regimen: Provided as a pre-packaged combipack, ensuring the correct dosages of both active ingredients are available for the patient.
Precautions
| Precaution | Description |
|---|---|
| Pregnancy Duration | Use only within the advised pregnancy period. |
| Ectopic Pregnancy | Not suitable for ectopic (outside uterus) pregnancy. |
| Heavy Bleeding Disorders | Use carefully if you have bleeding problems or anemia. |
| Liver or Kidney Disease | Inform if you have liver or kidney problems. |
| Long-Term Steroid Use | May not be suitable with long-term steroid treatment. |
| Allergy | Avoid if allergic to Mifepristone or Misoprostol. |
| Infection Risk | Seek care if fever, severe pain, or foul-smelling discharge occurs. |
Important Points
- Take the medicine exactly as directed.
- Bleeding and cramping are common during treatment.
- Follow-up may be needed to confirm completion.
- Seek urgent medical attention for very heavy bleeding, severe abdominal pain, or fainting.
Usage
Dosage and administration for this combination kit must be strictly followed under the guidance of a healthcare professional to ensure safety and efficacy. The procedure involves a two-step process with a specific waiting period between the two different medications.
| Step | Medication & Dose | Administration Guidelines |
| Step 1 | Mifepristone (1 Tablet - 200 mg) | Swallowed whole with water on day one in a clinical setting |
| Step 2 | Misoprostol (4 Tablets - 800 mcg) | Administered 24 to 48 hours after the first tablet |
| Method | Buccal or Vaginal | Misoprostol tablets are typically placed in the cheek pouches or inserted vaginally |
| Follow-up | Clinical Assessment | A mandatory visit is required 7 to 14 days later to confirm completion via ultrasound |
| Recovery | Home Care | Patients should remain in a comfortable environment with access to a telephone and medical support |
Uses
Medical Termination of Pregnancy: Primarily used for the medical abortion of an intrauterine pregnancy through 70 days (10 weeks) of gestation.
Early Pregnancy Loss Management: Occasionally utilized by healthcare providers to assist in the complete expulsion of tissue during a miscarriage (spontaneous abortion).
Cervical Priming: In specific clinical scenarios, the components may be used to help soften and dilate the cervix prior to other gynecological procedures.
Progesterone Regulation: The Mifepristone component is specifically used to block the hormonal support needed for the pregnancy to continue.
Induction of Uterine Shedding: The Misoprostol component is used to trigger the necessary physical process to clear the uterine cavity.
FAQs
Q: What is Cenofi AMFY Kit used for?
A: Cenofi AMFY Kit is used for the medical termination of early pregnancy up to 9 weeks (63 days) of gestation. It contains two medicines, Mifepristone and Misoprostol, that work together to safely end a pregnancy.
Q: How does Cenofi AMFY Kit work?
A: Mifepristone blocks the hormone progesterone which is needed to sustain a pregnancy, causing the lining of the uterus to break down. Misoprostol is then taken 24 to 48 hours later to cause the uterus to contract and expel the pregnancy.
Q: How is Cenofi AMFY Kit taken?
A: The kit is taken in two stages. Mifepristone is taken first orally as directed by a doctor. After 24 to 48 hours, Misoprostol is taken either orally, sublingually (under the tongue), or vaginally as instructed by your doctor.
Q: How effective is Cenofi AMFY Kit?
A: When used correctly and within the recommended timeframe, the combination of Mifepristone and Misoprostol is highly effective, with a success rate of approximately 95 to 98 percent in terminating early pregnancy.
Q: What are the common side effects of Cenofi AMFY Kit?
A: Common side effects include cramping, heavy bleeding, nausea, vomiting, diarrhoea, dizziness, headache, and fever. These are generally expected as part of the process. Contact your doctor if symptoms become severe or prolonged.
Q: How much bleeding is normal after taking Cenofi AMFY Kit?
A: Some degree of bleeding and cramping is expected and is a sign that the medication is working. However, if you are soaking more than two thick sanitary pads per hour for two consecutive hours, seek immediate medical attention.
Q: When should I seek emergency medical help?
A: Seek immediate medical attention if you experience heavy or prolonged bleeding, severe abdominal pain, high fever lasting more than 24 hours, foul-smelling vaginal discharge, or if you suspect the pregnancy has not been terminated.
Q: Can Cenofi AMFY Kit be used for ectopic pregnancy?
A: No. Cenofi AMFY Kit is not suitable for ectopic pregnancy (a pregnancy outside the uterus). Using it for an ectopic pregnancy can be life-threatening. Always confirm the location of the pregnancy with your doctor before use.
Q: Who should not use Cenofi AMFY Kit?
A: Cenofi AMFY Kit should not be used by patients with ectopic pregnancy, adrenal gland problems, bleeding disorders, those on long-term corticosteroid therapy, or those allergic to Mifepristone or Misoprostol. It should not be used beyond 9 weeks of gestation.
Q: Will I need a follow-up appointment after taking Cenofi AMFY Kit?
A: Yes. A follow-up appointment with your doctor is essential, usually 1 to 2 weeks after taking the medication, to confirm that the pregnancy has been completely terminated and that there are no complications.
Q: Can Cenofi AMFY Kit affect future pregnancies?
A: When used correctly under medical supervision, Cenofi AMFY Kit does not affect future fertility or pregnancies. However, it is important to attend all follow-up appointments to ensure complete termination and rule out any complications.
Interactions
| Drug / Group | Effect with CENOFI AMFY Kit (Mifepristone + Misoprostol) |
|---|---|
| Blood thinners | May increase risk of heavy bleeding. |
| Steroid medicines | Mifepristone may reduce steroid effectiveness. |
| NSAIDs (pain relievers) | Certain pain relievers may be used cautiously during treatment. |
| Antibiotics | Some antibiotics may affect how the medicine works. |
| Antifungal medicines | May change medicine levels in the body. |
| Anti-seizure medicines | May reduce effectiveness of treatment. |
| Herbal supplements | Some herbal products may affect results or bleeding risk. |
Important Points
- Inform your healthcare provider about all medicines and supplements you are taking.
- Do not combine with other medicines without guidance.
- Watch for heavy bleeding or unusual symptoms.
- Follow-up may be needed after treatment.
| Manufacturer | : | Mankind Pharma, India |
| Trade Name | : | MTP kit |
| Generic Search | : | mifepristone + misoprostol |
| Strength | : |
Latest Products
